Clinical trial
Hereditary Paraganglioma: Evaluation of Screening Methods to Detect Tumors in…
NCT00188019 · University Hospital, Angers, Other · Completed
Key facts
| NCT number | NCT00188019 |
|---|---|
| Title | Hereditary Paraganglioma: Evaluation of Screening Methods to Detect Tumors in SDH Positive Carriers |
| Official title | Evaluation Des méthodes de dépistage du Paragangliome héréditaire Chez Les Sujets prédisposés génétiquement |
| Lead sponsor | University Hospital, Angers, Other |
| Collaborators | Assistance Publique - Hôpitaux de Paris |
| Status | Completed |
| Study type | Interventional |
| Conditions | Paraganglioma, Pheochromocytoma |
| Intervention type | Procedure |
| Interventions | diagnosis methods |
| Enrollment | 248 |
| Start date | Nov 1, 2005 |
| Primary completion | Nov 1, 2013 |
| Completion | Nov 1, 2013 |
| First posted | Sep 16, 2005 |
| Last update posted | Jul 23, 2015 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: